… A double-blind, randomized controlled trial was conducted in … , to evaluate the prophylactic
effect of artemether (ART) given in … Chinese trials of artemisinin derivatives for prevention of S. …

… This study shows that arterolane–piperaquine–mefloquine is an efficacious and safe treatment
for uncomplicated falciparum malaria in children and could potentially be used to prevent …

… preventing transmission after currently used ACT regimens has not been formally assessed.
A dose-finding study … lowest efficacious dose of primaquine for preventing transmission [12]. …

… ) compared with 2 to 3 weeks with artemether-lumefantrine (AL). Each … As this is a placebo
controlled trial, the sampling … prevent malaria transmission after treatment: a double-blind, …

… The study was a randomized, double-blind, single-dose, multi-arm clinical trial in patients
aged > 6 months to < 70 years, from six African countries and Vietnam. Patients were followed …

… This study showed that the dihydroartemisinin–piperaquine combination had similar efficacy
and tolerability as artemether–lumefantrine combination. The added value of this study is …

… The use of triple ACTs could extend the useful therapeutic lifetimes of existing
antimalarials, because of the mutual protection between the two partner drugs. Artemether–lumefantrine …

… Study design and participants We did a randomised, double-blind, placebo-controlled, parallel
three arm, superiority trial at the Jaramogi Oginga Odinga Teaching and Referral Hospital …

… Uncomplicated malaria episodes were treated with oral quinine (first trimester) or
artemether–lumefantrine (subsequent trimesters), and severe malaria episodes with parenteral …

… This randomized, single-blind, placebo-controlled, single-center phase 1 … This study
supports the investigation of the combination of artemether-lumefantrine and ruxolitinib in healthy …